High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue (ASCR) for patients with previously irradiated recurrent medulloblastoma

被引：0
|
作者：
Dunkel, Ira [1 ]
Gardner, Sharon [2 ]
Garvin, James [3 ]
Goldman, Stewart [4 ]
Shi, Weiji [1 ]
Finlay, Jonathan [5 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] NYU, Med Ctr, New York, NY 10016 USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY USA
[4] Childrens Mem Hosp, Chicago, IL 60614 USA
[5] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：480 / 480
页数：1
相关论文
共 50 条
  • [1] High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue (ASCR) for recurrent medulloblastoma
    Dunkel, I
    Gardner, S
    Garvin, J
    Goldman, S
    Shi, WJ
    Finlay, J
    NEURO-ONCOLOGY, 2004, 6 (04) : 453 - 453
  • [2] High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma
    Dunkel, Ira J.
    Gardner, Sharon L.
    Garvin, James H., Jr.
    Goldman, Stewart
    Shi, Weiji
    Finlay, Jonathan L.
    NEURO-ONCOLOGY, 2010, 12 (03) : 297 - 303
  • [3] High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma
    Dunkel, IJ
    Boyett, JM
    Yates, A
    Rosenblum, M
    Garvin, JH
    Bostrom, BC
    Goldman, S
    Sender, LS
    Gardner, SL
    Li, H
    Allen, JC
    Finlay, JL
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 222 - 228
  • [4] HIGH-DOSE THIOTEPA, CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA
    Gevorgian, Asmik
    Tolkunova, Polina
    Iukhta, Tatiana
    Kazantsev, Ilya
    Morozova, Elena
    Andreeva, Tatiana
    Kozlov, Andrew
    Safonova, Svetlana
    Punanov, Yury
    Zubarovskaya, Ludmila
    Zheludkova, Olga
    Afanasyev, Boris
    NEURO-ONCOLOGY, 2018, 20 : 121 - 121
  • [5] RESULTS OF HIGH-DOSE THIOTEPA, CARBOPLATIN AND ETOPOSIDE WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RECURRENT MEDULLOBLASTOMA
    Gevorgian, Asmik
    Tolkunova, Polina
    Kazantsev, Ilya
    Iukhta, Tatiana
    Kozlov, Andrew
    Zvyagintseva, Darya
    Morozova, Elena
    Zubarovskaya, Ludmila
    Afanasiev, Boris
    Zheludkova, Olga
    Punanov, Yury
    NEURO-ONCOLOGY, 2020, 22 : 387 - 387
  • [6] HIGH-DOSE CHEMOTHERAPY WITH STEM CELL RESCUE FOR RECURRENT PREVIOUSLY IRRADIATED MEDULLOBLASTOMA
    Salnikova, Ekaterina
    Vilesova, Irina
    Merishavyan, Artur
    Druy, Alexander
    Yasko, Ludmila
    Sysoev, Andrey
    Nechesnyuk, Alexey
    Borodina, Irina
    Karachunsky, Alexander
    Novichkova, Galina
    Papusha, Ludmila
    NEURO-ONCOLOGY, 2020, 22 : 395 - 395
  • [7] High-dose busulfan and thiotepa followed by autologous stem cell transplantation in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy
    Valteau-Couanet, D
    Filippini, B
    Benhamou, E
    Kalifa, C
    Grill, J
    Hartmann, O
    BONE MARROW TRANSPLANTATION, 2004, 33 : S220 - S220
  • [8] High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer
    deMagalhaesSilverman, M
    Rybka, WB
    Lembersky, B
    Bloom, EJ
    Lister, J
    Pincus, SM
    Voloshin, M
    Wilson, J
    Ball, ED
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (02): : 169 - 173
  • [9] High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy
    Valteau-Couanet, D
    Fillipini, B
    Benhamou, E
    Grill, J
    Kalifa, C
    Couanet, D
    Habrand, JL
    Hartmann, O
    BONE MARROW TRANSPLANTATION, 2005, 36 (11) : 939 - 945
  • [10] High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy
    D Valteau-Couanet
    B Fillipini
    E Benhamou
    J Grill
    C Kalifa
    D Couanet
    J L Habrand
    O Hartmann
    Bone Marrow Transplantation, 2005, 36 : 939 - 945
12345